HOME >> BIOLOGY >> NEWS
OSA symptoms more common among African-American women than Caucasians

WESTCHESTER, Ill. In a study that examined the relationship between race, menopausal status and symptoms of obstructive sleep apnea (OSA), middle-aged African-American women were found to be more likely to experience OSA symptoms than their Caucasian counterparts, according to a research abstract that will be presented Monday at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

Elizabeth Beothy, of the University of Pennsylvania, who authored the study, administered a questionnaire to 269 subjects, with an average age of 48, and 49.4 percent of which were African-American. Further, 37.5 percent of women were pre-menopausal, 43 percent in the menopausal transition and 19.5 percent post-menopausal.

The mean apnea score among African-American women was nearly double that of Caucasian women. Menopausal status was not a significant predictor of OSA symptoms. Race remained a significant predictor of OSA symptoms after adjustment for current body mass index (BMI), BMI change over time and menopausal status.

"Although menopausal status did not predict OSA symptoms, OSA symptoms on our cohort of menopausal women increased with higher BMI and larger BMI increases over time," said Beothy, who added that studies to document whether OSA is more common among African-American women than Caucasian women should be performed to further investigate these findings.

OSA affects an estimated 15 million to 20 million Americans, as well as millions more who remain undiagnosed and untreated.

Scientific evidence shows that CPAP is the best treatment for sleep apnea. CPAP provides a steady stream of pressurized air to patients through a mask that they wear during sleep. This airflow keeps the airway open, preventing the pauses in breathing that characterize OSA and restoring normal oxygen levels.


'"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
11-Jun-2007


Page: 1

Related biology news :

1. Manganese levels increase in scrapie-infected sheep before clinical symptoms develop
2. MIT researchers reverse symptoms in mice of leading inherited cause of mental retardation
3. Latest data shows MabThera provides significant, sustained relief from symptoms of RA
4. Gene malfunctions cause schizophrenia, depression symptoms in mice
5. Switching genes to overdrive improves muscular dystrophy symptoms in mice
6. Reversal of symptoms in an autism spectrum disorder
7. Malaria drug may treat metabolic syndromes many symptoms
8. Brain protein improves stroke symptoms in rats, even when injected after 3 days
9. Rush and UCSF found gene therapy appeared to reduce symptoms of Parkinsons by 40 percent
10. Epilepsy drug eases symptoms of inherited disorder that weakens muscles
11. Researchers reverse Parkinsons symptoms in animal models

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... 1, 2016 The report "Biometric ... Future Technology (Iris Recognition System), Vehicle Type (Passenger ... Forecast to 2021", published by MarketsandMarkets, the market ... 2016, and is projected to grow to USD ... 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... -- higi SH llc (higi) announced today the launch ... industry thought-leaders and celebrity influencers looking to encourage, ... steps to live healthier, more active lives. ... built the largest self-screening health station network in ... have conducted over 185 million biometric screenings.  The ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... and SAN DIEGO , Dec. ... the appointment of Santosh Kesari , MD, PhD, ... will leverage his experience in neurology and clinical trials ... stem cell for treatment of stroke. The AmnioStem product is ... which has previously shown therapeutic activity in animal models ...
(Date:12/6/2016)... , Dec. 6, 2016  SRI International has ... million from the National Institutes of Health,s National ... Division of AIDS (NIAID-DAIDS) to support the manufacturing ... pre-exposure (PreP) agents. Under the seven-year contract, SRI ... development services for candidate HIV-prevention products that emerge ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... company focused on discovery and development of precision treatments for neurodegenerative diseases, ... for Alzheimer’s disease (AD) inhibited the direct neurotoxic effect of prion-like forms ...
(Date:12/5/2016)... Dec. 5, 2016 Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced that ... treatment of Alzheimer,s disease will be presented at the ... Friday, December 9, 2016 in San Diego ... of both simple and complex measures of activities of ...
Breaking Biology Technology:
Cached News: